Eiger BioPharmaceuticals, Inc. (EIGRQ)
USD 8.5
(6.25%)
USD 8.5
(6.25%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -74.96 Million USD | 22.54% |
| 2022 | -96.77 Million USD | -185.33% |
| 2021 | -33.91 Million USD | 47.86% |
| 2020 | -65.05 Million USD | 7.4% |
| 2019 | -70.25 Million USD | -34.09% |
| 2018 | -52.39 Million USD | -23.42% |
| 2017 | -42.44 Million USD | 9.85% |
| 2016 | -47.08 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -22.78 Million USD | 9.36% |
| 2023 Q4 | -13.45 Million USD | 25.38% |
| 2023 FY | -74.96 Million USD | 22.54% |
| 2023 Q2 | -20.69 Million USD | 9.17% |
| 2023 Q3 | -18.03 Million USD | 12.88% |
| 2022 Q3 | -27.11 Million USD | -23.89% |
| 2022 Q1 | -22.64 Million USD | -4.02% |
| 2022 FY | -96.77 Million USD | -185.33% |
| 2022 Q4 | -25.13 Million USD | 7.28% |
| 2022 Q2 | -21.88 Million USD | 3.35% |
| 2021 Q4 | -21.76 Million USD | 2.05% |
| 2021 FY | -33.91 Million USD | 47.86% |
| 2021 Q3 | -22.22 Million USD | -15.9% |
| 2021 Q2 | -19.17 Million USD | 0.0% |
| 2020 FY | -65.05 Million USD | 7.4% |
| 2019 FY | -70.25 Million USD | -34.09% |
| 2018 FY | -52.39 Million USD | -23.42% |
| 2017 FY | -42.44 Million USD | 9.85% |
| 2016 FY | -47.08 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -5513.394% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -973.532% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 241.496% |
| Nascent Biotech, Inc. | -2.08 Million USD | -3490.729% |
| Rebus Holdings, Inc. | -1.02 Million USD | -7249.314% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 215.092% |
| Qrons Inc. | -789.34 Thousand USD | -9396.837% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -11753.601% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -19.751% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -17942.548% |
| Skye Bioscience, Inc. | -37.64 Million USD | -99.133% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -1039.929% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -27318.6% |
| SQZ Biotechnologies Company | -79.46 Million USD | 5.664% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -2491.729% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -4017.652% |
| Mesoblast Limited | -87.95 Million USD | 14.772% |
| Marizyme, Inc. | -65.34 Million USD | -14.715% |
| Genus plc | 7.9 Million USD | 1048.899% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -588.255% |
| Pharming Group N.V. | -10.54 Million USD | -610.684% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -3354.812% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -1920.439% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -747.614% |
| ContraFect Corporation | -65.15 Million USD | -15.057% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -1434.221% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -4239.505% |
| IMV Inc. | -36.48 Million USD | -105.459% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -830.099% |
| MultiCell Technologies, Inc. | -380.07 USD | -19723371.992% |
| ONE Bio Corp. | 8.67 Million USD | 963.966% |
| Accustem Sciences Inc. | -3.74 Million USD | -1900.924% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -45.019% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -5815.949% |
| Q BioMed Inc. | -2.05 Million USD | -3553.002% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -1908.117% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -3048.555% |
| Biomind Labs Inc. | -1.21 Million USD | -6073.254% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -25.513% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -2316.783% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -848.527% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -3745.738% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -500454.22% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -372.314% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -1188.632% |
| GB Sciences, Inc. | -1.36 Million USD | -5405.197% |
| Alpha Cognition Inc. | -13.77 Million USD | -444.292% |
| HST Global, Inc. | -146.21 Thousand USD | -51170.775% |
| CSL Limited | 2.64 Billion USD | 102.837% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -4171.953% |
| Halberd Corporation | -79.67 Thousand USD | -93984.793% |
| Enzolytics Inc. | -2.17 Million USD | -3343.674% |
| Agentix Corp. | -1.37 Million USD | -5354.985% |
| Resverlogix Corp. | -3.61 Million USD | -1976.537% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -2263.693% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 74.593% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 76592.857% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 1182.562% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -1786.814% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -2377.186% |
| AVAX Technologies, Inc. | -6.41 Million USD | -1068.804% |
| Zenith Capital Corp. | -10.59 Million USD | -607.465% |
| Genscript Biotech Corporation | -95.47 Million USD | 21.486% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -322432.484% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -1708.108% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -123927.537% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -3638.589% |
| Kadimastem Ltd | -3.3 Million USD | -2166.525% |
| Helix BioMedix, Inc. | -1.05 Million USD | -6998.386% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -1862.896% |
| BioStem Technologies, Inc. | -8.48 Million USD | -783.687% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -16884.201% |
| LadRx Corporation | 400.44 Thousand USD | 18820.018% |
| Cell Source, Inc. | -5.32 Million USD | -1308.758% |
| Regen BioPharma, Inc. | 1.02 Million USD | 7424.124% |
| Regen BioPharma, Inc. | 1.02 Million USD | 7424.124% |
| NovAccess Global Inc. | -4.76 Million USD | -1471.819% |
| Affymax, Inc. | -14.42 Million USD | -419.71% |
| Itoco Inc. | -1.86 Million USD | -3910.872% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -1587.392% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -4391.492% |
| Mobile Lads Corp. | -2.26 Million USD | -3212.122% |
| CytoDyn Inc. | -49.84 Million USD | -50.404% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -94750.252% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -32760.205% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -7861.837% |
| SYBLEU INC | -180.3 Thousand USD | -41475.894% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -4548.185% |
| International Stem Cell Corporation | -131 Thousand USD | -57123.664% |
| Bioxytran, Inc. | -4.28 Million USD | -1651.471% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -138024.631% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -2862.675% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -55.939% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -3446.026% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -9499.724% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -2266.256% |
| Neutra Corp. | -233.46 Thousand USD | -32008.881% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -269.44% |
| PureTech Health plc | -65.69 Million USD | -14.104% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -252.493% |
| IXICO plc | -1.17 Million USD | -6263.582% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -655.143% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -31.219% |
| CSL Limited | 2.64 Billion USD | 102.837% |
| Cellectis S.A. | -103.17 Million USD | 27.343% |